Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Tatsch

Showing results (71-80 of 139) with videos related to

Pageof 14
Sort By:
Nuclear Medicine Communications|September 1, 1990
67Ga-scintigraphy for evaluation of AIDS-related intestinal infectionsK Tatsch, P Knesewitsch, A Matuschke, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 17, 2002
Steele-Richardson-Olszewski-syndrome: the relation of dopamine D2 receptor binding and subcortical lesions in MRIG Arnold, J Schwarz, K Tatsch, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 1990
Functional and morphological findings in early and advanced stages of HIV infection: a comparison of 99mTc-HMPAO SPECT with CT and MRI studiesK Tatsch, E Schielke, W M Bauer, et al.
Archives of Neurology|February 19, 2000
Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosisJ Schwarz, R Linke, M Kerner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2002
European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligandsK Tatsch, S Asenbaum, P Bartenstein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2002
European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligandsK Tatsch, S Asenbaum, P Bartenstein, et al.
Journal of Diabetes and Its Complications|October 23, 1997
Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitusO Schnell, D Muhr, M Weiss, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonismJ Schwarz, K Tatsch, T Gasser, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 1998
Parkinson's disease and tumour in the supplementary motor area: a re-evaluationA Kupsch, O Pogarell, J Schwarz, et al.
Nuclear Medicine Communications|October 1, 1994
Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonismJ Schwarz, A Antonini, K Tatsch, et al.
Pageof 14

Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Nuclear Medicine Communications|September 1, 1990
67Ga-scintigraphy for evaluation of AIDS-related intestinal infectionsK Tatsch, P Knesewitsch, A Matuschke, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 17, 2002
Steele-Richardson-Olszewski-syndrome: the relation of dopamine D2 receptor binding and subcortical lesions in MRIG Arnold, J Schwarz, K Tatsch, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 1990
Functional and morphological findings in early and advanced stages of HIV infection: a comparison of 99mTc-HMPAO SPECT with CT and MRI studiesK Tatsch, E Schielke, W M Bauer, et al.
Archives of Neurology|February 19, 2000
Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosisJ Schwarz, R Linke, M Kerner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2002
European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligandsK Tatsch, S Asenbaum, P Bartenstein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2002
European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligandsK Tatsch, S Asenbaum, P Bartenstein, et al.
Journal of Diabetes and Its Complications|October 23, 1997
Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitusO Schnell, D Muhr, M Weiss, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonismJ Schwarz, K Tatsch, T Gasser, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 1998
Parkinson's disease and tumour in the supplementary motor area: a re-evaluationA Kupsch, O Pogarell, J Schwarz, et al.
Nuclear Medicine Communications|October 1, 1994
Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonismJ Schwarz, A Antonini, K Tatsch, et al.
Pageof 14